A new Molecular Biology tool has been developed to screen for interactions between a protein of interest, and the pool of proteins of an ORFeome (15000 proteins), through Bimolecular Fluorescence Complementation (BiFC). This technology lies on immortalized and transformed cell banks that are transfected with a plasmid incorporating the protein of interest, and on a detection of protein-protein couples by FACS (Fluorescence-activated cell sorting). It allows an accurate and reliable method to study the impact of protein inhibitors or promotors for drug development.
PULSALYS is looking for :
> industrial partners interested in (co-)developing and commercializing this product,
> business profiles interested in entrepreneurship / startup.